ACLX
ACLX
NASDAQ · Biotechnology

Arcellx Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$115.07
+0.00 (+0.00%)
As of Aug 1, 1:26 AM ET ·
Analyst Consensus
Hold
14
Analysts
Moderate
Coverage
Buy 0 0%
Hold 11 79%
Sell 3 21%
Price Target
Analyst Price Target -15.7% upside
Low Target $73.10
Average Target $96.95
High Target $131.09
Current Price $115.07
Current
$115.07
Target
$96.95
$73.10 $96.95 avg $131.09
Scenario Analysis
Bear Case
$73.10
-36.5%
Low target
Base Case
$96.95
-15.7%
Avg target
Bull Case
$131.09
+13.9%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$115.13
-0.1% from high
52-Week Low
$60.36
+90.7% from low
50-Day SMA
$112.63
+2.2% vs SMA
200-Day SMA
$84.18
+36.7% vs SMA
RSI (14)
73.1
Overbought
Target vs 52W High
$96.95
-15.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%